NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES
TORONTO, ON–(Marketwired – November 03, 2015)
PharmaCan Capital Corp. (TSX VENTURE: MJN) (“PharmaCan” or the “Company”) announces that is has served the Barnes Family Trust (“BFT”) with Notice that it will participate fully in the Share Purchase Agreement (“SPA”) that the BFT entered into for the sale of all of their shares in Peace Naturals (see press release dated October 9th, 2015).
PharmaCan owns 662,992 shares of Peace Naturals. According to the SPA it is expected that the purchase price will be at or above $7.00 a share.
Completion of the sale is subject to the approval of the TSX Venture. There is no assurance the sale will be completed. Completion is subject to risks beyond the control of PharmaCan including risks related to BFT, the BFT purchaser, Peace Naturals, market conditions and regulatory approvals.
About PharmaCan Capital Corp.
PharmaCan is a company in the business of investing in companies either licensed, or actively seeking a license, to produce medical marihuana pursuant to Canada’s MMPR. PharmaCan has a diversified portfolio of investments including investments in 5 of the 26 companies licensed by Health Canada to produce medical marihuana.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.